Tag: Motley Fool

Investing money in blue-chip shares after the stock market crash could be a profitable long-term move. In some cases, high-quality businesses are currently trading at prices that do not fully reflect their long-term growth potential.

Furthermore, the stock market has a long track record of recovery from downturns. Therefore, even if there is another market crash, the prospects for equities over the coming years could prove to be positive.

Meanwhile, a lack of return potential elsewhere may mean that stocks outperform other assets. This could make now the right time to build a diverse portfolio of shares.

Undervalued blue-chip shares

Many blue-chip shares currently face uncertain operating conditions that may persist for a number of months. However, in many cases those risks appear to have been priced in by investors. A wide range of stocks currently trade at prices that are significantly below their long-term averages. In some cases, today’s valuations have not been seen since the last bear market during the global financial crisis over a decade ago.

Buying undervalued shares can prove to be a sound move. It allows an investor to access a high-quality business at a low price that can provide scope for greater capital returns over the coming years. Certainly, cheap shares can become even less expensive in the short run. However, their long-term prospects may be much more positive than current valuations suggest.

Recovery potential after a stock market crash

Another reason to invest in blue-chip shares is their long-term recovery prospects. The stock market has experienced numerous corrections, bear markets and downturns in its long history. While they have been painful in the short term for many investors, indexes such as the S&P 500 Index (SP: .INX) and FTSE 100 Index (FTSE: UKX) have always recovered to post fresh highs in the following years.

At the present time, a stock market recovery may seem somewhat unlikely. Risks such as a weak economic outlook and coronavirus mean that investor sentiment may deteriorate in the short run. However, the stock market’s track record suggests that growth from its current level via a sustained bull market is likely to take place in the coming years.

Relative appeal of stocks

Blue-chip shares may face an uncertain near-term outlook. However, their long-term return prospects appear to be far more attractive than those of other mainstream assets.

For example, low interest rates mean that cash and bonds offer return prospects that are potentially lower than inflation. This could hurt an individual’s spending power over the long run. Meanwhile, high house prices and gold’s rise in 2020 may mean that there is better value for money in the stock market.

Through buying a diverse portfolio of blue-chip shares, an investor could profit from low prices and a likely long-term recovery. Therefore, now could be the right time to buy stocks, rather than other assets.

More reading

• Are ASX lithium shares making a comeback?
• Primero (ASX:PGX) share price surges 10% on takeover news
• Catapult (ASX:CAT) share price lower despite announcing a new acquisition
• Mayne Pharma (ASX:MYX) share price falls on results update
• Why the Telix (ASX:TLX) share price is surging 8%

Motley Fool contributor Peter Stephens has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post 3 reasons why I’d invest money in blue-chip shares at today’s prices appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/37549uX

The Catapult Group International Ltd (ASX: CAT) share price is trading lower on Tuesday after announcing an acquisition.

At the time of writing, the sports analytics and wearables company’s shares are down 1% to $2.07.

What did Catapult announce?

This morning Catapult announced the acquisition of subscription online sport learning platform, Science for Sport.

According to the release, Science for Sport was founded in 2016 and has grown into the number one source for content, online courses, and community engagement in the global sports science industry.

It has built an organic social audience of hundreds of thousands of followers, becoming one of the most-trusted sources of information for sport practitioners around the world.

The release explains that the platform empowers athletes and teams with easy to consume answers to their performance-related questions, addressing key sports issues such as athlete agility, mitigation of soft tissue injuries, and enhanced recovery methods.

What else does Science for Sport offer?

Science for Sport has two core paid products. The first is an online magazine that summarises the latest sports science research into relatable and applicable content.

The second is a library of educational courses focused on topics such as nutrition, coaching, and performance, with thousands of members around the globe.

Management notes that through its dedicated focus to advance the sports science industry, it has built a community where knowledge, best practices, and world-class research and content is shared, while generating positive free cash flow.

Catapult began partnering with Science for Sport at the beginning of this year. It notes that it has been extremely impressed with the reach, engagement, and influence of the platform.

As such, management believes this acquisition will accelerate Catapult’s development of its professional service solutions by providing professional and amateur customers with advanced training and education through industry-leading content and online courses.

Catapult’s Chief Executive Officer, Will Lopes, commented: “Science for Sport has built the pre-eminent content platform and community for the fast-growing, intelligent, and influential world of sports science.”

“We are excited at the prospect of growing Science for Sport’s content and helping its audience learn how technology solutions can accelerate performance of teams and athletes. This strategic acquisition will help us, and the sports technology industry, to scale even faster,” he added.

No details were provided in relation to how much Catapult paid for the acquisition.

More reading

• Why the Catapult (ASX:CAT) share price is racing 12% higher today
• Top ASX shares to buy in November 2020

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Catapult Group International Ltd. The Motley Fool Australia has recommended Catapult Group International Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Catapult (ASX:CAT) share price lower despite announcing a new acquisition appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/39hrV9M

The Mayne Pharma Group Ltd (ASX: MYX) share price has fallen 2.82% to 34 cents in early trading today, after the company reported a 9% drop in revenue for the first four months of FY21.

Mayne Pharma is a pharmaceutical company that commercialises branded and generic drugs. The business provides contract development and manufacturing services to more than 100 clients worldwide. It earns 90% of its revenue from the US.

What did Mayne Pharma report today?

Mayne Pharma advised that its revenue declined by 9% to $140 million for the four months up to October. The company said this was due to a weakening USD foreign exchange rate which depreciated 3 cents to US$ 71.5 cents, as well as a softer generic result.

Generics products division revenue was US$55 million in the first four months of FY21, down 10%. This was due to weaker performance in methylphenidate, amiodarone and butalbital.

Profit margin has remained consistent year on year at 47%, and operating expenses have fallen by 20% or $10 million, benefiting from the restructure undertaken in FY20, and continued cost containment.

Restructuring and strategy

Mayne Pharma says it has worked extensively on minimising its cost base by $16 million in 2020. A significant part of these savings have been in its dermatology business, where restructuring of the sales team has driven a more profitable operating model.

In addition, research and development (R&D) spend decreased by $15m. The company says while it continued to invest in R&D and business development activities, it has refocused from the more volatile retail generic segment to more sustainable areas in women’s health, dermatology and infectious disease.

What did the company report for FY20?

Back in August, Mayne Pharma announced its full year results for FY20. The company reported a net loss of $93 million driven mainly by asset impairments. This result was achieved on the back of a full year revenue of $457 million, which was down 13% from the prior year.

In October,  the company suffered a setback when the US Food and Drugs Administration (FDA) raised questions in relation to the company’s generic version of the drug Nuvaring. The share price fell by 16% on the news that day.

About the Mayne Pharma share price in 2020

The Mayne Pharma share price has fallen by almost 20% this year. It started the year at 43 cents, and is now trading at 34 cents. The company commands a market cap of $587 million.

More reading

• 2 ASX healthcare shares that have risen since Pfizer’s vaccine news

Motley Fool contributor Eddy Sunarto has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Mayne Pharma (ASX:MYX) share price falls on results update appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3996Cax

Telix Pharmaceuticals Ltd (ASX: TLX) shares are rocketing higher this morning after the company announced the United States Food and Drug Administration (FDA) approved its new drug application (NDA) for a prostate cancer imaging product. In early morning trade, the Telix share price is trading 8.1% higher at $3.07.

NDA approval

Investors are driving up the Telix share price today after news that the FDA has accepted the company’s NDA for TLX591-CDx (kit for the preparation of Ga-PSMA-11). The prostate cancer imaging product is a radiopharmaceutical targeting Prostate-Specific Membrane Antigen (PSMA). It uses a Positron Emission Tomography (PET) to scan for the disease.

Telix’s NDA submission for its prostate cancer imaging product included clinical data from over 600 patients. These were obtained from the studies undertaken by Telix and its research partners. Additionally, clinical evidence was reported in peer-reviewed medical literature, which was conducted from leading global academic centres. The highly reputable group includes the University of California (United States), the Peter MacCallum Cancer Centre (Australia) and Heidelberg University Hospital (Germany).

About prostate cancer

Prostate cancer is the second most common cancer in men, after skin cancer. In 2018 alone, 1.3 million men were diagnosed with prostate cancer for the first time. Despite advances in treatment, prostate cancer still accounts for a large number of deaths. That same year, over 365,000 men died from the disease. As rates of diagnosis are improving, the highest number of incidents are occurring in Europe, the United States, Australia, and New Zealand.

What did management say?

Telix CEO, Dr Christian Behrenbruch, commented on the approved NDA. He said:

We are delighted to have achieved this significant milestone with the FDA’s acceptance for filing of the first commercial NDA for PSMA imaging in the United States. This represents a major step towards our goal of providing this highly anticipated product to patients in the United States and beyond.

From acquiring ANMI4 and its advanced chemistry platform in December 2018, to successfully filing an NDA less than two years later, represents an extraordinary achievement by the Telix team. We now look forward to working with the FDA to bring TLX591-CDx to American patients living with prostate cancer as expeditiously as possible.

Furthermore, Telix Chief Medical Officer, Dr Colin Hayward, talked about the importance of the company’s product, adding:

The use of Ga-PSMA PET imaging is rapidly becoming the standard of care for prostate cancer imaging across a broad range of clinical settings. PSMA imaging is already included in the leading clinical practice guidelines in the United States and Europe, based on evidence that definitively demonstrates superiority over conventional imaging.

Telix share price summary

Telix first listed on the ASX in November 2017. With today’s rise, the Telix share price has hit a new, all-time high after notching up a previous high of $2.94 just last week. It was only at the start of November that the Telix share price jumped more than 30%. This came after news of the company’s strategic partnership with China Grand Pharmaceutical and Healthcare Holdings (CGP) set a new record for the Telix share price.

More reading

• Why IDP Education, Sandfire, Telix, & Treasury Wine shares are dropping lower
• Why Abacus, Amaysim, CSR, & Telix shares stormed higher today
• Telix (ASX:TLX) share price jumps 30% to an all-time high. Here’s why.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Why the Telix (ASX:TLX) share price is surging 8% appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2UWPw7z

The NEXTDC Ltd (ASX: NXT) share price is pushing higher today after the release of an announcement.

In morning trade the data centre operator’s shares are up almost 1.5% to $12.05.

What did NEXTDC announce?

This morning NEXTDC announced that it has upsized its new senior debt facilities following a strong response in syndication from a diverse set of new and existing banks and institutional investors.

According to the release, the company has lifted its new senior debt facilities by $350 million to a total of $1.85 billion.

The release explains that the senior debt facilities will remain split across three tranches, each with a tenor of five years. This comprises $800 million for a term loan facility, $400 million for a capital expenditure facility, and $650 million for a multi-currency revolving credit facility.

NEXTDC expects the financial close for the senior debt facilities to occur prior to the redemption of the $800 million in unsecured notes on 9 December 2020.

Following redemption of the notes, on a pro-forma basis, the company will have liquidity of approximately $1.95 billion. This comprises cash of $893 million and undrawn debt under the new senior debt facilities of $1.05 billion.

NEXTDC’s CEO and Managing Director, Craig Scroggie, commented: “The level of support from our existing and new lending partners has significantly exceeded expectations, with the revised debt facilities heavily oversubscribed.”

“The ability to upsize this transaction highlights the quality, maturity, and resilience of the business that NEXTDC have built over the last ten years. NEXTDC now has an enhanced funding runway to continue to invest in our best-in-class facilities to support the growth of our customers in our key markets,” he concluded.

Why is NEXTDC doing this?

When this debt deal was announced last month, management advised that the new facilities provide a significant improvement in NEXTDC’s weighted average cost of debt and duration profile. Furthermore, they come with materially improved financial covenants and flexibility.

In addition to this, it also gives the company greater funding firepower as it executes on its development pipeline in the coming years to satisfy growing customer demand.

This could include an international expansion. At its annual general meeting this month, NEXTDC revealed that it now has offices in Singapore and Tokyo and is working with key customers and talking to respective governments about a potential expansion in the region.

At the event it also reconfirmed its guidance for FY 2021. The company’s underlying EBITDA guidance remains $125 million to $130 million. This represents year on year growth of 20% to 24%.

More reading

• 5 fantastic ASX shares to buy today
• These were the worst performing ASX 200 shares last week
• 3 ASX shares rated as buys by brokers
• ASX 200 down 0.35%: Ramsay Q1 update, NEXTDC’s international expansion, gold miners surge
• NEXTDC (ASX:NXT) share price edges higher on AGM update

Motley Fool contributor James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Why the NEXTDC (ASX:NXT) share price is climbing higher today appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/375LmzV

The TechnologyOne Ltd (ASX: TNE) share price is pushing higher this morning following the release of its full year results.

In morning trade, the enterprise software company’s shares are up 1.5% to $9.14.

How did TechnologyOne perform in FY 2020?

In FY 2020, TechnologyOne delivered a 4% increase in total revenue to $299 million. This was driven largely by its software-as-a-service (SaaS) business, which continues to growth strongly.

During the 12 months, the company reported SaaS Annual Recurring Revenue (ARR) of $134.6 million. This was a 32% increase on the prior corresponding period and up 22.1% from $110.2 million in the first half.

This was driven by the addition of 104 enterprise customers to its Global SaaS ERP solution, bringing the total to 539 large scale enterprise customers, with hundreds of thousands of users. Management notes that this makes it the largest single instance SaaS ERP offering in Australia.

On the bottom line, thanks to a combination of its SaaS growth and good cost control, the company’s underlying profit before tax came in at $82.5 million. This was up 13% year on year and compares favourably to its guidance range of 8% to 12% growth for FY 2020.

Also growing was TechnologyOne’s reported cash flows. It generated cash flow of $66.4 million, up 49% year on year. This led to its cash and cash equivalents increasing by 19% to $125.2 million.

In light of its positive performance and strong balance sheet, the TechnologyOne board declared a full year dividend of 12.88 cents per share. This is an increase of 8% year on year.

Outlook.

Management is expecting to see strong continuing growth in SaaS ARR and profit in FY 2021. Though, it stopped short of providing any firm guidance.

It also spoke very positively about its long term growth potential.

It commented: “As our SaaS business continues to grow quickly, the quality of this revenue stream is exceptionally high, given its recurring contractual nature, combined with our very low churn rate of <1%. Today our Total Annual Recurring Revenue (ARR) has hit $222m and is set to exceed $500m in the coming years.”

Management was equally positive on its earnings growth prospects.

“Underlying Profit Before Tax margin increased to 29%, compared to 27% pcp. We see margins continuing to improve to 35%+ in the coming years driven by the significant economies of scale from our single instance multi-tenanted Global SaaS ERP solution. We are on track to double the size of our business once again in the next five years,” it concluded.

More reading

• 5 things to watch on the ASX 200 on Tuesday
• ASX 200 events this week that could move the market
• How to turn $20,000 into $180,000 in 10 years with ASX shares
• Here’s where this ASX fund manager is investing right now

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post TechnologyOne (ASX:TNE) share price higher on strong FY 2020 results appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3603Qma

Qantas Airways Limited (ASX: QAN) will make COVID-19 vaccination compulsory for international passengers, according to its chief executive.

Qantas boss, Alan Joyce, told A Current Affair on Monday night that the airline is currently looking at adding a clause to its terms and conditions to “ask people to have a vaccination before they can get on the aircraft”.

“Certainly, for international visitors coming out and people leaving the country, we think that’s a necessity.”

Whether the rule would apply to domestic flights would depend on how the coronavirus situation evolves within the country.

Joyce expected Qantas wouldn’t be alone in requiring proof of vaccination as a condition of carriage.

“Talking to my colleagues in other airlines around the globe, I think it’s going to be a common theme,” he said.

“What we’re looking at is how you can have a vaccination passport, an electronic version of it, that certifies what the vaccine is. Is it acceptable to the country that you’re travelling to?”

International travel will return next year

With 3 different vaccines now showing promise, Joyce was excited to think international travel might be making a big comeback.

“We’re optimistic we could see the borders opening up significantly throughout 2021.”

While Australia’s international border has been shut, Qantas has been making government-organised repatriation flights to bring Australians home.

And these operations have allowed it to implement anti-virus measures, such as COVID testing passengers before and after they board.

“We’re testing the wastewater on the plane as well,” Joyce said.

The airline’s executive spoke as the usually busy Sydney-Melbourne route reopened on Monday.

He is hoping that, by Christmas, 60% of pre-COVID business will have returned.

“If we can get Melbourne and Sydney back to where it was pre-COVID that will be 3000 people that didn’t have a role… that are working for the airline again.”

The news came as the Transport Workers’ Union has made a last-minute pitch to save 2,400 ground crew jobs from being outsourced.

Qantas’ relationship with the union requires the latter to have a chance to bid for the work alongside outsourcing companies. The Australian Financial Review reported Tuesday that the TWU had finally made its submission last week.

The Qantas share price closed Monday’s session 1.71% higher at $5.36.

More reading

• JobKeeper saved 700,000 jobs, reveals RBA
• Why ASX shares are in awesome shape vs overseas markets
• Qantas (ASX: QAN) share price on the rise as more flights resume
• Why the Helloworld (ASX:HLO) share price is climbing higher today
• Revealed: Shares that’ll shoot up with a COVID-19 recovery

Motley Fool contributor Tony Yoo owns shares of Qantas Airways Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Qantas (ASX:QAN) to make COVID vaccine mandatory for passengers appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2HuaxDv

Earlier this month, payments platform company Pushpay Holdings Ltd (ASX: PPH) announced it will undertake a four-for-one share split. This means that each share held in the company before the share split will turn into four shares after the split takes place.

This process kicks off today, Tuesday 24 November, so here’s what you need to know.

Why is Pushpay splitting its shares?

Traditionally, share splits have been a way to make share ownership more accessible for smaller investors like you and me. That’s because companies with high share prices can be out of reach for investors if they can only purchase whole shares.

Imagine trying to buy a whole share (or more!) in Warren Buffett’s Berkshire Hathaway Inc (NYSE: BRK.A) (NYSE: BRK.B). The Berkshire Hathaway share price was a phenomenal US$341,000 per share in November 2020. The CSL Limited (ASX: CSL) share price of around $317 per share is certainly more accessible, but even that could be a challenge if you only had $300 to invest.

This is less of a problem with newer investing platforms that offer fractional share investing, where you can invest fixed dollar amounts and buy part-shares. Still, the additional quantity of shares means there are more shares available to change hands as Pushpay noted in its announcement: “The Pushpay Board considers that the share split will assist to enhance liquidity in the market for Pushpay’s ordinary shares.”

Has Pushpay split its shares before?

Yes, this isn’t the first time Pushpay has split its shares. Pushpay previously completed a four-for-one share split in February 2016.

At that time, Pushpay was only listed on the New Zealand stock exchange, but the company says it saw a positive impact from the split. In its most recent November announcement, Pushpay noted that the previous split resulted in “a meaningful increase in both the shareholder base and liquidity that was partly attributable to the share split.”

The other part, of course, is likely to do with the company’s impressive growth profile. Pushpay revenue has rocketed from NZ$15 million in the 2016 financial year to NZ$187 million (US$129.8 million) in the 2020 financial year.

When is the Pushpay share split happening?

Today, Tuesday 24 November, is the last date for trading in Pushpay shares on a pre-share split basis.

What happens then? Well from the start of trading on 25 November until market close on Friday 27 November, Pushpay shares will trade as if the share split has occurred. This means that, all else being equal, the Pushpay share price will drop to around one quarter of the previous day’s closing price.  

However, it’s worth noting that over this period, Pushpay shares will trade on the ASX under the temporary ticker ‘PPHDA’ and trades will be made on a deferred settlement basis, so settlement will occur on Wednesday 2 December 2020.

From Monday 30 November 2020, things will return to normal and the Pushpay share price will be found under the ‘PPH’ ticker with regular settlement times.

Do share splits increase a company’s value?

Share splits have no impact on a company’s fundamental valuation, but when the share price is high, a split can make it easier for individual investors to buy shares in the company.

This was a factor behind big name share splits in the United States this year, with both Apple Inc (NASDAQ: AAPL) shares and Tesla Inc (NASDAQ: TSLA) shares splitting into smaller slices. However, with the Pushpay share price trading around $7.64 at the time of the announcement, it’s likely that having more shares outstanding available to buy and sell was a larger driver for Pushpay’s split. 

More reading

• 3 compelling ASX payment shares rated as buys
• 2 great ASX shares to buy
• 5 fantastic ASX shares to buy today
• 2 ASX growth shares predicting big growth this decade
• Down 22% in 3 weeks, is the Pushpay (ASX:PPH) share price a buy?

Regan Pearson has no position in any of the stocks mentioned. You can follow him on Twitter @Regan_Invests.

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Apple, Berkshire Hathaway (B shares), and Tesla. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and PUSHPAY FPO NZX and recommends the following options: long January 2021 $200 calls on Berkshire Hathaway (B shares), short January 2021 $200 puts on Berkshire Hathaway (B shares), and short December 2020 $210 calls on Berkshire Hathaway (B shares). The Motley Fool Australia has recommended Apple, Berkshire Hathaway (B shares), and PUSHPAY FPO NZX. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Regan Pearson has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Apple, Berkshire Hathaway (B shares), and Tesla. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and PUSHPAY FPO NZX and recommends the following options: long January 2021 $200 calls on Berkshire Hathaway (B shares), short January 2021 $200 puts on Berkshire Hathaway (B shares), and short December 2020 $210 calls on Berkshire Hathaway (B shares). The Motley Fool Australia has recommended Apple, Berkshire Hathaway (B shares), and PUSHPAY FPO NZX. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Everything you need to know about the Pushpay (ASX:PPH) share split appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3frTuyf

The Brickworks Limited (ASX: BKW) share price will be on watch this morning after the release of a trading update ahead of its annual general meeting.

How is Brickworks performing in FY 2021?

According to the release, the Building Products Australia business has started FY 2021 strongly and has delivered first quarter earnings well ahead of the prior corresponding period.

Brickworks’ Managing Director, Mr. Lindsay Partridge, commented: “Our home builder customers have a solid pipeline of work for the remainder of the financial year, underpinned by the various government stimulus measures currently in place in each state.”

Mr Partridge revealed that the company was pro-active throughout the pandemic and worked hard to accelerate several important growth initiatives. This includes the introduction of a range of innovative new bricks, roof tiles, and masonry products.

The managing director also provided an update on its significant capital program. He expects this to strengthen its competitive position in a number of key markets. Part of this is the construction of its $75 million Austral Masonry plant in Sydney, which is well on track for commissioning in 2021.

North America.

Over in North America things are not quite as positive due to the pandemic. Management notes that there is short term uncertainty in the region, with the recent surge in infections causing ongoing disruptions to sales activity and manufacturing operations.

However, it is pleased with the underlying performance of the business and the progress achieved against its strategic priorities. Management notes that in August, it opened its new design studio in central Philadelphia. It believes this will further enhance its strong position in the high value architectural segment.

Looking ahead, management is confident that once conditions normalise, its North American operations will deliver improved earnings and growth for many years to come.

Property Trust.

One area which is performing particularly strongly is its Property Trust business with Goodman Group (ASX: GMG).

Since the end of the financial year, the construction of the state-of-the-art Amazon facility at Oakdale West is advancing and due to be complete in September 2021. Major infrastructure works are also proceeding to schedule and will allow construction of the Coles Group Ltd (ASX: COL) distribution warehouse to commence early in calendar 2021.

Following the completion of these two facilities, net rental distributions will increase by over 25%, and gross assets held within the Property Trust is expected to exceed $3 billion. There is also sufficient remaining land to provide at least a further five-year development pipeline.

Outlook.

Management believes that Brickworks is in a strong position, with a conservative debt level and a diversified portfolio of attractive assets.

Mr Partridge commented: “Within Building Products Australia, we have made an encouraging start to the year and our customers are reporting a strong pipeline of work in place. However, in North America conditions are more challenging, due to the ongoing impact of COVID-19. Of course, until a vaccine becomes widely available, there remains considerable uncertainty in both markets.”

“Another strong half is expected for Property, and WHSP is expected to deliver a stable and growing stream of earnings and dividends over the long term,” he concluded.

More reading

• ASX 200 events this week that could move the market
• 3 leading ASX dividend shares to buy for income
• Get real: 2 ASX dividend shares to boost your income stream
• Leading brokers name 3 ASX shares to sell today
• Why Afterpay, Goodman, MedAdvisor, & PointsBet shares are dropping lower

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Brickworks. The Motley Fool Australia owns shares of COLESGROUP DEF SET. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Brickworks (ASX:BKW) share price on watch after trading update appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/3pUvnNI

Bitcoin and other cryptocurrencies have not enjoyed a solid reputation as a ‘stable’ asset class, or even as an asset at all. Warren Buffett’s right-hand man Charlie Munger even famously referred to bitcoin as worthless, artificial gold, rat poison and, er.. excrement.

Even though cryptocurrencies have been around for more than a decade (with the past few years pushing them into the mainstream), they remain outside the realm of conventional ASX investing vehicles like managed and exchange-traded funds (ETFs). Possibly hindering this elevation is the infamous volatility of the cryptocurrency scene, as well as controversy arising from the decentralised, stateless nature of the assets themselves.

However, we could be seeing a turning point in this orthodoxy.

Bitconnect?

According to reporting in the Australian Financial Review (AFR), the head of bond, income and defensive strategies at ASX fund manager Pendal Group Ltd (ASX: PDL), Vimal Gor, is increasingly bullish on cryptos and bitcoin in particular.

The AFR reports that Mr. Gor now has active positions in bitcoin futures on the Chicago Mercantile Exchange, quoting Mr. Gor on the reasons for this move:

There are over 7000 cryptocurrencies in the world. We are only looking at one, which is bitcoin… It has a futures contract so even though it’s a new asset, the way it trades is like any other asset. To buy bitcoin, you don’t have to be part of the tinfoil hat brigade… All the big hitters in the hedge fund world are coming out to endorse bitcoin now; it is entering the realm of the mainstream.

Bitcoin comes out of the woodwork

But Mr. Gor is not the only fund manager coming out in support of the cryptocurrency. The AFR quotes 2 other fund managers, Stan Druckenmiller and Paul Tudor Jones, on the matter.

Mr. Druckenmiller stated: “I have warmed up to the fact that bitcoin could be an asset class that has a lot of attraction as a store of value to Millennials.”

Mr. Tudor Jones agrees: “I’m not a bitcoin flag bearer but bitcoin has this enormous contingent of really smart, sophisticated people who believe in it. You have a crowd of people who are dedicated to seeing bitcoin succeed in it becoming a store of value”.

But it’s not just the ‘mainstreaming’ of cryptocurrency as a separate asset class that’s attracting Pendal to bitcoin, it’s also the shrinking effectiveness of alternative asset classes thanks to quantitative easing. Mr Gor told the AFR as much:

We think ultimately that government bonds will turn into a dead asset class, so we now have to imagine what it will be like for other assets classes when bonds are no longer relevant to hold in a portfolio… obviously commodities and cryptocurrencies have a part to play in the answer… Bitcoin is a cockroach that exists. They can’t ban it out of existence.

More reading

• How the pandemic is making some investors super-rich
• ASX 200 Weekly Wrap: US election special
• These were the worst performing ASX 200 shares last week
• Why Domino’s, Estia Health, Pendal, & Treasury Wine shares are dropping lower
• Pendal (ASX:PDL) share price falls 7% on disappointing FY20 result

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post ASX fund manager turns to bitcoin for returns appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/35Y2nMX